Hepion Pharmaceuticals, Inc. Announces Reverse Stock Split
Provided By Globe Newswire
Last update: May 10, 2023
EDISON, N.J., May 10, 2023 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial Intelligence (“AI”)-driven therapeutic drug development for the treatment of fibrotic diseases, including non-alcoholic steatohepatitis (“NASH”), hepatocellular carcinoma (“HCC”), and other chronic diseases, announced that it will effect a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-20, effective as of 4:01 p.m. Eastern Time today, May 10, 2023. Hepion common stock will begin trading on a split-adjusted basis when the market opens on May 11, 2023 under the existing trading symbol “HEPA.”
0.318
-0.07 (-18.79%)
Find more stocks in the Stock Screener
HEPA Latest News and Analysis
2 hours ago - ChartmillWhich stocks are moving after the closing bell on Monday?The regular session of the US market on Monday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
5 days ago - ChartmillGet insights into the top gainers and losers of Wednesday's after-hours session.Let's have a look at what is happening on the US markets after the closing bell on Wednesday. Below you can find the top gainers and losers in today's after hours session.
